IL-10-Dependent Infectious Tolerance after the Treatment of Experimental Allergic Encephalomyelitis with Redirected CD4+CD25+T Lymphocytes
How small numbers of CD4+CD25+regulatory T cells suppress autoimmune responses in vivo is unclear. In this report we analyze the immunomodulatory activity of CD4+CD25+T cells that are antigen-specifically redirected against myelin basic protein (MBP)89-101-specific autoreactive T cells by a MBP89-10...
Saved in:
Published in: | Proceedings of the National Academy of Sciences - PNAS Vol. 102; no. 33; pp. 11817 - 11822 |
---|---|
Main Authors: | , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
National Academy of Sciences
16-08-2005
National Acad Sciences |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | How small numbers of CD4+CD25+regulatory T cells suppress autoimmune responses in vivo is unclear. In this report we analyze the immunomodulatory activity of CD4+CD25+T cells that are antigen-specifically redirected against myelin basic protein (MBP)89-101-specific autoreactive T cells by a MBP89-101- IAs-ζ chimeric receptor. We have previously shown that these redirected regulatory T cells are highly potent in treating a model autoimmune disease, experimental allergic encephalomyelitis. We show here that they have only limited effect in vivo on autoreactive T cell proliferation and therefore do not act by deleting or suppressing the expansion of pathologic effector cells. Rather, the redirected CD4+CD25+T cells divert the pathologic T helper 1 self-specific T cell response to one characterized by high IL-10 and lower IL-4 production. Significantly, when isolated from the inducing CD4+CD25+regulatory T cells, these self-specific T cells can independently suppress the autoreactive T cell response and experimental allergic encephalomyelitis development in an IL-10-dependent manner. These results provide evidence that CD4+CD25+regulatory T cells can manipulate the adaptive immune response in vivo through the infectious induction of tolerance, specifically by promoting the formation of antigen-specific, IL-10-secreting regulatory T cells. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Communicated by Richard A. Flavell, Yale University School of Medicine, New Haven, CT, June 28, 2005 Author contributions: D.J.M., R.S.A., and T.L.G. designed research; D.J.M. and R.S.A. performed research; D.J.M., R.S.A., and T.L.G. analyzed data; and D.J.M. and T.L.G. wrote the paper. Abbreviations: Tg, transgenic; EAE, experimental allergic encephalomyelitis; RMTC, receptor-modified T cell; MBP, myelin basic protein; PLP, proteolipid protein; LN, lymph node; Th, T helper. To whom correspondence should be addressed at: Department of Pathology, St. Jude Children's Research Hospital, 332 North Lauderdale Street, D-4047, Memphis, TN 38105. E-mail: terrence.geiger@stjude.org. |
ISSN: | 0027-8424 1091-6490 |
DOI: | 10.1073/pnas.0505445102 |